ACKR3 | Atypical chemokine receptor 3 | Cancer-related genes G-protein coupled receptors Predicted membrane proteins
| | | | | Expressed in all |
APLF | Aprataxin and PNKP like factor | Enzymes G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
BAI2 | Brain-specific angiogenesis inhibitor 2 | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
C5AR1 | Complement component 5a receptor 1 | CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CELSR1 | Cadherin, EGF LAG seven-pass G-type receptor 1 | Disease related genes G-protein coupled receptors Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
CHRM3 | Cholinergic receptor, muscarinic 3 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
FZD1 | Frizzled class receptor 1 | Cancer-related genes G-protein coupled receptors Plasma proteins Predicted membrane proteins Transporters
| | | | | Mixed |
FZD10 | Frizzled class receptor 10 | CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GPR132 | G protein-coupled receptor 132 | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
GPR160 | G protein-coupled receptor 160 | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
GPRC5A | G protein-coupled receptor, class C, group 5, member A | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GPRC5B | G protein-coupled receptor, class C, group 5, member B | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GRPR | Gastrin-releasing peptide receptor | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
HRH1 | Histamine receptor H1 | FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
KISS1R | KISS1 receptor | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins Transporters
| | | | | Not detected |
LPHN2 | Latrophilin 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
MRGPRF | MAS-related GPR, member F | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
NMBR | Neuromedin B receptor | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
NPFFR2 | Neuropeptide FF receptor 2 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NTSR1 | Neurotensin receptor 1 (high affinity) | G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
PTAFR | Platelet-activating factor receptor | G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Mixed |
SSTR2 | Somatostatin receptor 2 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
SSTR5 | Somatostatin receptor 5 | FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |